Driehaus Capital Management’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-254,274
| Closed | -$35.6M | – | 525 |
|
|
2018
Q4 | $35.6M | Sell |
254,274
-27,425
| -10% | -$4.16M | 1.52% | 7 |
|
|
2018
Q3 | $48.1M | Sell |
281,699
-25,654
| -8% | -$4.31M | 1.48% | 7 |
|
|
2018
Q2 | $53.3M | Sell |
307,353
-98,262
| -24% | -$14.8M | 1.8% | 7 |
|
|
2018
Q1 | $46.8M | Sell |
405,615
-168,880
| -29% | -$18M | 1.65% | 7 |
|
|
2017
Q4 | $48.4M | Buy |
574,495
+164,959
| +40% | +$13.8M | 1.83% | 5 |
|
|
2017
Q3 | $37.7M | Buy |
409,536
+51,895
| +15% | +$4.03M | 1.47% | 6 |
|
|
2017
Q2 | $28.7M | Sell |
357,641
-241,222
| -40% | -$13.4M | 1.05% | 15 |
|
|
2017
Q1 | $25.2M | Buy |
598,863
+175,587
| +41% | +$7.23M | 0.86% | 23 |
|
|
2016
Q4 | $13.6M | Buy |
423,276
+80,511
| +23% | +$2.06M | 0.48% | 35 |
|
|
2016
Q3 | $8.97M | Buy |
342,765
+27,741
| +9% | +$726K | 0.3% | 68 |
|
|
2016
Q2 | $7.3M | Sell |
315,024
-16,017
| -5% | -$399K | 0.26% | 85 |
|
|
2016
Q1 | $9.05M | Sell |
331,041
-22,057
| -6% | -$462K | 0.29% | 65 |
|
|
2015
Q4 | $10M | Sell |
353,098
-87,328
| -20% | -$2.34M | 0.34% | 69 |
|
|
2015
Q3 | $7.7M | Sell |
440,426
-25,290
| -5% | -$495K | 0.28% | 89 |
|
|
2015
Q2 | $8.4M | Buy |
465,716
+83,695
| +22% | +$1.14M | 0.29% | 82 |
|
|
2015
Q1 | $4.76M | Sell |
382,021
-1,627
| -0.4% | -$20.3K | 0.16% | 155 |
|
|
2014
Q4 | $4.51M | Buy |
383,648
+18,082
| +5% | +$211K | 0.18% | 159 |
|
|
2014
Q3 | $4.8M | Buy |
+365,566
| New | +$4.74M | 0.18% | 149 |
|
Other funds holding LOXO
Driehaus Capital Management's LOXO Position: Q1 2019 in Review
Driehaus Capital Management sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 254,274 shares — an estimated $35.6M sold.
Driehaus Capital Management first reported a position in LOXO in Q3 2014 and held it in 18 quarters. The position peaked at $53.3M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.
- Driehaus Capital Management reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
- Driehaus Capital Management sold 254,274 Loxo Oncology, Inc shares in Q1 2019, an estimated $35.6M.
- Driehaus Capital Management first reported a position in Loxo Oncology, Inc in Q3 2014 and held it in 18 quarters.
- Driehaus Capital Management's Loxo Oncology, Inc position peaked at $53.3M in Q2 2018.
- 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.
Based on Driehaus Capital Management's 13F filing for Q1 2019, filed 15 May 2019.